-
21
-
22
Utilities Associated with the Treatment of Growth Hormone Deficiency (GHD): A Time Trade-off (TTO) Study in the UK and Canada
Published 2025-01-01“…Susan Kirsch,1 Gary Butler,2 Lasse de Fries Jensen,3 Anna Okkels,4 Cecilie Yssing,4 Jonas Håkan-Bloch3 1Department of Pediatric Endocrinology, Hospital for Sick Children, Toronto and Oak Valley Health Hospital, Markham, Ontario, Canada; 2Department of Paediatric Endocrinology, University College London Hospitals, and UCL Great Ormond Street Institute of Child Health, London, UK; 3Novo Nordisk, Søborg, 2860, Denmark; 4EY Godkendt Revisionspartnerselskab, Frederiksberg, 2000, DenmarkCorrespondence: Lasse de Fries Jensen, Novo Nordisk, Vandtårnsvej 108-110, Søborg, 2860, Denmark, Tel +45 34482020, Email LDFJ@novonordisk.comPurpose: Growth hormone deficiency (GHD) causes decreased growth rate in children, resulting in short stature in childhood and adulthood. …”
Get full text
Article -
23
-
24
-
25
From economics to health outcomes: Delving into the significance of reduced insulin prices
Published 2024-08-01“… The recent substantial price reductions in insulin therapy by major manufacturers prompt an examination of their impact on South Africa (SA)’s healthcare. While Eli Lilly, Novo Nordisk, and Sanofi cut prices on long-acting basal insulin, among others, significantly, these insulins are not on SA’s Essential Medicines List (EML) for primary healthcare. …”
Get full text
Article -
26
Leveraging haplotype information in heritability estimation and polygenic prediction
Published 2025-01-01Get full text
Article -
27
-
28
-
29
LPS Counter Regulates RNA Expression of Extracellular Proteases and Their Inhibitors in Murine Macrophages
Published 2012-01-01Get full text
Article -
30
Knowledge about diabetes in Malmö prior to initiation of “Cities Changing Diabetes”
Published 2025-01-01Get full text
Article -
31
-
32
-
33
-
34
-
35
Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAs
Published 2025-01-01Get full text
Article -
36
Diabetes medication prescribing trends based on provider type and location in the United States
Published 2025-01-01Get full text
Article -
37
“Does the Response to Morning Medication Predict the ADL-Level of the Day in Parkinson’s Disease?”
Published 2020-01-01Get full text
Article -
38
Targeted maximum likelihood based estimation for longitudinal mediation analysis
Published 2025-01-01Get full text
Article -
39
-
40